MIBG Therapy for Pheochromocytomas and Paragangliomas
2 Ansichten
administrator
07/02/23
Dr. David Mankoff discusses meta-Iodobenzylguanidine (MIBG) therapy, which is a highly targeted therapy for treatment of pheochromocytomas and paragangliomas, at the 2012 Focus on Neuroendocrine Tumors Conference.
Zeig mehr
Facebook Kommentare
Keine Kommentare gefunden